These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 6986637

  • 1. Immunotherapy of cancer: current status.
    Goodnight JE, Morton DL.
    Prog Exp Tumor Res; 1980; 25():61-88. PubMed ID: 6986637
    [No Abstract] [Full Text] [Related]

  • 2. Immunotherapy from malignant disease.
    Goodnight JE, Morton DL.
    Annu Rev Med; 1978; 29():231-83. PubMed ID: 348035
    [No Abstract] [Full Text] [Related]

  • 3. BCG as adjuvant immunotherapy for neoplasia.
    Hersh EM, Gutterman JU, Mavligit GM.
    Annu Rev Med; 1977; 28():489-515. PubMed ID: 324372
    [No Abstract] [Full Text] [Related]

  • 4. Biologic response modifiers as adjuncts to other therapeutic modalities.
    Borden EC, Hawkins MJ.
    Semin Oncol; 1986 Jun; 13(2):144-52. PubMed ID: 2424086
    [No Abstract] [Full Text] [Related]

  • 5. Immunotherapy of cancer.
    Salmon SE, Jones SE.
    Ariz Med; 1977 Jun; 34(6):396-8. PubMed ID: 880051
    [No Abstract] [Full Text] [Related]

  • 6. Immunotherapy of patients with cancer.
    Smith GV, Morse PA, Deraps GD, Raju S, Hardy JD.
    Surgery; 1973 Jul; 74(1):59-68. PubMed ID: 4715883
    [No Abstract] [Full Text] [Related]

  • 7. Introduction: Immunotherapy of cancer in man, a reality.
    Klein E.
    Natl Cancer Inst Monogr; 1973 Dec; 39():139-61. PubMed ID: 4206961
    [No Abstract] [Full Text] [Related]

  • 8. Active immunotherapy against cancer: present status.
    Morton DL.
    Semin Oncol; 1986 Jun; 13(2):180-5. PubMed ID: 3520826
    [No Abstract] [Full Text] [Related]

  • 9. Immunotherapy of human solid tumors with Bacillus Calmette-Guérin: prolongation of disease-free interval and survival in malignant melanoma, breast, and colorectal cancer.
    Gutterman JU, Mavligit GM, Blumenshein G, Burgess MA, McBride CM, Hersh EM.
    Ann N Y Acad Sci; 1976 Jun; 277(00):135-59. PubMed ID: 1069546
    [No Abstract] [Full Text] [Related]

  • 10. Clinical trials of immunotherapy: present status.
    Morton DL, Goodnight JE.
    Cancer; 1978 Nov; 42(5):2224-33. PubMed ID: 363256
    [Abstract] [Full Text] [Related]

  • 11. Immunotherapy for malignant disease.
    Med Lett Drugs Ther; 1976 Sep 24; 18(20):83-4. PubMed ID: 1066519
    [No Abstract] [Full Text] [Related]

  • 12. Immunotherapy and chemoimmunotherapy of malignant disease with BCG and nonviable mycobacterial fractions.
    Schwarz MA, Gutterman JU, Hersh EM, Richman SP, Mavligit GM.
    World J Surg; 1977 Sep 24; 1(5):555-83. PubMed ID: 272083
    [No Abstract] [Full Text] [Related]

  • 13. Active immunotherapy of cancer for minimal residual disease: new trends and new materials.
    Mathé G, Florentin I, Olsson L, Kiger N, Bruley-Rosset M, Orbach-Arbouys S, Schulz JI.
    Prog Exp Tumor Res; 1980 Sep 24; 25():242-74. PubMed ID: 6986635
    [No Abstract] [Full Text] [Related]

  • 14. Immunostimulation before chemotherapy in cancer treatment.
    Frati L, Barzi A, Caprino MC, Menconi E, Bonmassar E.
    Pharmacol Res Commun; 1977 Sep 24; 9(8):689-99. PubMed ID: 563086
    [No Abstract] [Full Text] [Related]

  • 15. Immunotherapy of malignancy in humans. Current status.
    Holmes EC, Eilber FR, Morton DL.
    JAMA; 1975 Jun 09; 232(10):1052-5. PubMed ID: 236402
    [Abstract] [Full Text] [Related]

  • 16. BCG, levamisole and transfer factor in the treatment of cancer.
    Spitler LE.
    Prog Exp Tumor Res; 1980 Jun 09; 25():178-92. PubMed ID: 6986631
    [No Abstract] [Full Text] [Related]

  • 17. Immunotherapy of human tumors.
    Sinkovics JG.
    Pathobiol Annu; 1978 Jun 09; 8():241-84. PubMed ID: 364375
    [No Abstract] [Full Text] [Related]

  • 18. Active specific immunotherapy and immunochemotherapy in the treatment of lung and colon cancer.
    Hollinshead A.
    Semin Surg Oncol; 1991 Jun 09; 7(4):199-210. PubMed ID: 1925251
    [Abstract] [Full Text] [Related]

  • 19. Experience gained in immunotherapy from the immunopharmacology of BCG leading to a second generation of systemic immunity adjuvants.
    Mathe G.
    Comp Immunol Microbiol Infect Dis; 1980 Jun 09; 3(4):407-32. PubMed ID: 6451350
    [No Abstract] [Full Text] [Related]

  • 20. The immunobiology of colorectal cancer.
    Mcdonald JS.
    Semin Oncol; 1976 Dec 09; 3(4):421-31. PubMed ID: 793017
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.